The ClpP peptidase of Wolbachia endobacteria is a novel target for drug development against filarial infections

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1790-1800

  Schiefer, Andrea ^a   Vollmer, Jennifer ^a   Lämmer, Christine ^a   Specht, Sabine ^a   Lentz, Christian ^a   Ruebsamen Schaeff, Helga ^b   Brötz Oesterhelt, Heike ^c   Hoerauf, Achim ^a   Pfarr, Kenneth ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b AiCuris GmbH   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acyldepsipeptides; Filariasis; Ftsz; Litomosoides sigmodontis

Indexed keywords

ACYLDEPSIPEPTIDE; CLPP PEPTIDASE; PEPTIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FILARIASIS; GERBIL; IN VITRO STUDY; INSECT CELL; NONHUMAN; WOLBACHIA; WORM;

ACYLDEPSIPEPTIDES; FILARIASIS; FTSZ; LITOMOSOIDES SIGMODONTIS;

ANTI-BACTERIAL AGENTS; DEPSIPEPTIDES; ENDOPEPTIDASE CLP; FILARICIDES; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; PROTEASE INHIBITORS; WOLBACHIA;

EID: 84880754677     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt105     Document Type: Article

References (46)

1. Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010; 376: 1175-85.
2. Udall DN. Recent updates on onchocerciasis: diagnosis and treatment. Clin Infect Dis 2007; 44: 53-60.
3. WHO. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2010; 365-72.
4. Hoerauf A, Pfarr K, Mand S et al. Filariasis in Africa-treatment challenges and prospects. Clin Microbiol Infect 2011; 17: 977-85.
5. WHO. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration. Wkly Epidemiol Rec 2011; 377-88.
6. Hoerauf A. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis 2008; 21: 673-81.
7. WHO. Meeting of the International Task Force for Disease Eradication, April 2011. Wkly Epidemiol Rec 2011; 86: 341-52.
8. Awadzi K, Boakye DA, Edwards G et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 2004; 98: 231-49.
9. Osei-Atweneboana MY, Eng JK, Boakye DA et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007; 369: 2021-9.
10. Osei-Atweneboana MY, Awadzi K, Attah SK et al. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 2011; 5: e998.
11. Hoerauf A, Nissen-Pahle K, Schmetz C et al. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 1999; 103: 11-8.
12. Bandi C, McCall JW, Genchi C et al. Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol 1999; 29: 357-64.
13. Casiraghi M, Anderson TJ, Bandi C et al. A phylogenetic analysis of filarial nematodes: comparison with the phylogeny of Wolbachia endosymbionts. Parasitology 2001; 122(Pt 1): 93-103.
14. Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001; 51: 2145-65.
15. Pfarr K, Hoerauf A. The annotated genome of Wolbachia from the filarial nematode Brugia malayi: what it means for progress in antifilarial medicine. PLoS Med 2005; 2: e110.
16. Taylor MJ, Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitol Today 1999; 15: 437-42.
17. Hoerauf A, Volkmann L, Hamelmann C et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 2000; 355: 1242-3.
18. Hoerauf A, Volkmann L, Nissen-Paehle K et al. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin. Trop Med Int Health 2000; 5: 275-9.
19. Hoerauf A, Mand S, Adjei O et al. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 2001; 357: 1415-6.
20. Supali T, Djuardi Y, Pfarr KM et al. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Clin Infect Dis 2008; 46: 1385-93.
21. Turner JD, Mand S, Debrah AY et al. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis 2006; 42: 1081-9.
22. Debrah AY, Mand S, Specht S et al. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2006; 2: e92.
23. Debrah AY, Mand S,Marfo-Debrekyei Y et al. Reductioninlevelsofplasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am J Trop Med Hyg 2009; 80: 956-63.
24. Debrah AY, Mand S, Marfo-Debrekyei Y et al. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health 2007; 12: 1433-41.
25. Hoerauf A, Specht S, Buttner M et al. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol 2008; 197: 295-311.
26. Specht S, Hoerauf A, Adjei O et al. Newly acquired Onchocerca volvulus filariae after doxycycline treatment. Parasitol Res 2009; 106: 23-31.
27. Michel KHK, R.E. A54556 antibiotics and process for production there of. US Patent 4492650, 1985.
28. Hinzen B, Raddatz S, Paulsen H et al. Medicinal chemistry optimization of acyldepsipeptides of the enopeptin class antibiotics. Chem Med Chem 2006; 1: 689-93.
29. Brötz-Oesterhelt H, Beyer D, Kroll HP et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med 2005; 11: 1082-7.
30. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006; 125: 443-51.
31. Effantin G, Maurizi MR, Steven AC. Binding of the ClpA unfoldase opens the axial gate of ClpP peptidase. J Biol Chem 2010; 285: 14834-40.
32. Lee BG, Park EY, Lee KE et al. Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism. Nat Struct Mol Biol 2010; 17: 471-8.
33. Kirstein J, Hoffmann A, Lilie H et al. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol Med 2009; 1: 37-49.
34. Li DH, Chung YS, Gloyd M et al. Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ ClpA-bound state of ClpP. Chem Biol 2010; 17: 959-69.
35. Sass P, Josten M, Famulla K et al. Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci USA 2011; 108: 17474-9.
36. Foster J, Ganatra M, Kamal I et al. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol 2005; 3: e121.
37. Henrichfreise B, Schiefer A, Schneider T et al. Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachi a: why is lipid II needed? Mol Microbiol 2009; 73: 913-23.
38. Ziewer S, Hubner MP, Dubben B et al. Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis. PLoS Negl Trop Dis 2012; 6: e1558.
39. Townson S, Tagboto S, McGarry HF et al. Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro. Filaria J 2006; 5: 4.
40. Bandi C, Anderson TJ, Genchi C et al. Phylogeny of Wolbachia in filarial nematodes. Proc Biol Sci 1998; 265: 2407-13.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
42. Landmann F, Bain O, Martin C et al. Both asymmetric mitotic segregation and cell-to-cell invasion are required for stable germline transmission of Wolbachia in filarial nematodes. Biology Open 2012; 1: 536-47.
43. Kirstein J, Moliere N, Dougan DA et al. Adapting the machine: adaptor proteins for Hsp100/Clp and AAA+ proteases. Nat Rev Microbiol 2009; 7: 589-99.
44. Fenollar F, Maurin M, Raoult D. Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR. Antimicrob Agents Chemother 2003; 47: 1665-71.
45. Nanninga N, Koppes LJ, de Vries-Tijssen FC. The cell cycle of Bacillus subtilis as studied by electron microscopy. Arch Microbiol 1979; 123: 173-81.
46. Bernhardt J, Weibezahn J, Scharf C et al. Bacillus subtilis during feast and famine: visualization of the overall regulation of protein synthesis during glucose starvation by proteome analysis. Genome Res 2003; 13: 224-37.